|
The prolactin receptor is a member of the cytokine receptor superfamily.
Like other members of that family, it has a single transmembrane domain,
and no intrinsic signaling activity. Several receptor isoforms, differing
in cytoplasmic domains, mediate the actions of prolactin and related hormones
at their targets. Those with truncated cytoplasmic domains have limited
ability to transduce signal. Target tissues differ in total amount of
receptor, as well as relative levels of the different receptor isoforms.
Despite recent advances in our understanding of the interactions of
these hormones with their receptors and signaling processes, relatively
little is known about the fate of the ligand and receptor after their
interaction at the plasma membrane, the mechanisms which mediate these
processes, and the relationship to hormone action. We have found that
the isoform with a full length cytoplasmic domain is internalized more
rapidly, resulting in a preponderance of the short isoform at the surface,
contributing to signal down-regulation.
We are currently focusing on the pathways whereby these receptors are
internalized, including differences in constitutive and ligand-stimulated
internalization as well as that employed by the different isoforms, and
identifying the mechanisms that lead to different outcomes. These studies
have important implications for modulation of the target tissue response
and therefore disease progression.
Publications
in this area:
Schuler,
L.A., R.M. Nagel, J. Gao, N.D. Horseman and M.A. Kessler. Prolactin
receptor heterogeneity in fetal and maternal tissues, Endocrinology
138:3187-3194, 1997. [Abstract]
Bignon,
C., N. Binart, C. Ormandy, L.A. Schuler, P.A. Kelly and J.
Djiane. Long and short forms of the ovine prolactin receptors: cDNA
cloning and genomic analysis reveal alternative splicing mechanisms
in ruminants and in rodents. J. Mol. Endocrinol. 19:109-120, 1997.
[Abstract]
[Full Text (PDF)]
Schuler,
L.A., J-C. Lu and J.L. Brockman Prolactin receptor heterogeneity:
Processing and signaling of the long and short isoforms during development. Biochem.
Soc. Trans. 29:52-56, 2001.
Lu,
J.-C., Scott, P., Strous, G.J., and L.A. Schuler. Multiple
internalization motifs differentially used by prolactin receptor
isoforms mediate similar endocytic pathways. Mol. Endocrinol., 16:2515-2527,
2002. [Abstract]
Lu,
J.-C, T.M. Piazza, and L.A. Schuler. Proteasomes
mediate prolactin-induced receptor down-regulation and fragment
generation in breast cancer cells. J. Biol. Chem. 280:33909-33916,
2005. [Abstract]
Piazza,
T.M., J.-C. Lu, K.C. Carver, and L.A. Schuler. Prolactin activation
of srcs accelerates receptor internalization, modulating trafficking
and signaling in breast cancer cells, submitted
|